Review



simnotrelvir sim0417  (Simcere Pharmaceutical Group)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Simcere Pharmaceutical Group simnotrelvir sim0417
    Simnotrelvir Sim0417, supplied by Simcere Pharmaceutical Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/simnotrelvir sim0417/product/Simcere Pharmaceutical Group
    Average 90 stars, based on 1 article reviews
    simnotrelvir sim0417 - by Bioz Stars, 2026-05
    90/100 stars

    Images



    Similar Products

    simnotrelvir sim0417  (Simcere Pharmaceutical Group)
    90
    Simcere Pharmaceutical Group simnotrelvir sim0417
    Simnotrelvir Sim0417, supplied by Simcere Pharmaceutical Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/simnotrelvir sim0417/product/Simcere Pharmaceutical Group
    Average 90 stars, based on 1 article reviews
    simnotrelvir sim0417 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    xiannuoxintm simnotrelvir (sim0417)  (Simcere Pharmaceutical Group)
    90
    Simcere Pharmaceutical Group xiannuoxintm simnotrelvir (sim0417)
    3CLpro inhibitors in preclinical and clinical trials. The table provides an overview of 3CLpro inhibitors in preclinical and clinical trials. Each row represents a specific molecule under investigation, with information about the 3CLpro inhibitors’ name, the pharmaceutical company responsible for their development, the route of administration, the current state of development, the inhibitory concentration (IC 50 ) in nanomolar for 3CLpro inhibitors in preclinical trials, the effective concentration (EC 50 ) in micromolar for 3CLpro inhibitors in preclinical or clinical trials, and the unique identifier (ID) of the registered clinical trial. These data offer a comprehensive perspective on 3CLpro inhibitors in the research and development phase for potential use in treating COVID-19.
    Xiannuoxintm Simnotrelvir (Sim0417), supplied by Simcere Pharmaceutical Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/xiannuoxintm simnotrelvir (sim0417)/product/Simcere Pharmaceutical Group
    Average 90 stars, based on 1 article reviews
    xiannuoxintm simnotrelvir (sim0417) - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    sim0417  (Simcere Pharmaceutical Group)
    90
    Simcere Pharmaceutical Group sim0417
    3CLpro inhibitors in preclinical and clinical trials. The table provides an overview of 3CLpro inhibitors in preclinical and clinical trials. Each row represents a specific molecule under investigation, with information about the 3CLpro inhibitors’ name, the pharmaceutical company responsible for their development, the route of administration, the current state of development, the inhibitory concentration (IC 50 ) in nanomolar for 3CLpro inhibitors in preclinical trials, the effective concentration (EC 50 ) in micromolar for 3CLpro inhibitors in preclinical or clinical trials, and the unique identifier (ID) of the registered clinical trial. These data offer a comprehensive perspective on 3CLpro inhibitors in the research and development phase for potential use in treating COVID-19.
    Sim0417, supplied by Simcere Pharmaceutical Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sim0417/product/Simcere Pharmaceutical Group
    Average 90 stars, based on 1 article reviews
    sim0417 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    3CLpro inhibitors in preclinical and clinical trials. The table provides an overview of 3CLpro inhibitors in preclinical and clinical trials. Each row represents a specific molecule under investigation, with information about the 3CLpro inhibitors’ name, the pharmaceutical company responsible for their development, the route of administration, the current state of development, the inhibitory concentration (IC 50 ) in nanomolar for 3CLpro inhibitors in preclinical trials, the effective concentration (EC 50 ) in micromolar for 3CLpro inhibitors in preclinical or clinical trials, and the unique identifier (ID) of the registered clinical trial. These data offer a comprehensive perspective on 3CLpro inhibitors in the research and development phase for potential use in treating COVID-19.

    Journal: Viruses

    Article Title: 3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials

    doi: 10.3390/v16060844

    Figure Lengend Snippet: 3CLpro inhibitors in preclinical and clinical trials. The table provides an overview of 3CLpro inhibitors in preclinical and clinical trials. Each row represents a specific molecule under investigation, with information about the 3CLpro inhibitors’ name, the pharmaceutical company responsible for their development, the route of administration, the current state of development, the inhibitory concentration (IC 50 ) in nanomolar for 3CLpro inhibitors in preclinical trials, the effective concentration (EC 50 ) in micromolar for 3CLpro inhibitors in preclinical or clinical trials, and the unique identifier (ID) of the registered clinical trial. These data offer a comprehensive perspective on 3CLpro inhibitors in the research and development phase for potential use in treating COVID-19.

    Article Snippet: XiannuoxinTM: Simnotrelvir (SIM0417) and Ritonavir (SSD8432) , Simcere , Oral , Phase II/III , 9 , 34 , NCT05373433 [ ] .

    Techniques: Clinical Proteomics, Concentration Assay